Q2 2017

Filed Aug 9, 2017 · 10-Q · 40 days after period end · 0001558370-17-006414

Q2 2017 · 10-Q

Revenue

$3.56M

no prior Q2 2016 on file

Net Income

-$21.12M

N/M vs Q2 2016

EPS Diluted

-$0.72

N/M vs Q2 2016

Operating Income-$21,258,000N/M

Operating Cash Flow

Same quarter

Metric	Q2 2017	Q2 2016	Q2 2015	Q2 2014
Revenue	$3.56M	—	—	—
Net Income	-$21.12M	-$24.52M	-$4.67M	-$4.12M
EPS Diluted	-$0.72	-$1.05	-$0.45	-$5.33

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Collegium Pharmaceutical, Inc · CIK 1267565 · Engraved from SEC EDGAR